Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
Emerg Infect Dis
    April 2024
  1. FUKUNAGA R, Pierre P, Williams JK, Briceno-Robaugh R, et al
    Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
    Emerg Infect Dis. 2024;30:1-5.
    >> Share

  2. DAHL VN, Butova T, Rosenthal A, Grinev A, et al
    Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022.
    Emerg Infect Dis. 2024;30:831-833.
    >> Share

  3. GURREY SO, Strick LB, Dov LK, Miller JS, et al
    Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
    Emerg Infect Dis. 2024;30:S17-S20.
    >> Share

    March 2024
  4. SPIES R, Hong HN, Trieu PP, Lan LK, et al
    Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
    Emerg Infect Dis. 2024;30:499-509.
    >> Share

  5. GUNTHER G, Mhuulu L, Diergaardt A, Dreyer V, et al
    Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
    Emerg Infect Dis. 2024;30:568-571.
    >> Share

    January 2024
  6. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
    Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
    Emerg Infect Dis. 2024;30:136-140.
    >> Share

  7. HUMAYUN M, Mukasa L, Ye W, Bates JH, et al
    Racial and Ethnic Disparities in Tuberculosis Incidence, Arkansas, USA, 2010-2021.
    Emerg Infect Dis. 2024;30:116-124.
    >> Share

  8. NSENGIYUMVA NP, Khan A, Gler MMTS, Tonquin ML, et al
    Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018-2021.
    Emerg Infect Dis. 2024;30:79-88.
    >> Share

    December 2023
  9. LAFLEUR M, Rasoanaivo HA, Andrianarivo TH, Andrianomanana FR, et al
    Tuberculosis in Lemurs and a Fossa at National Zoo, Madagascar, 2022.
    Emerg Infect Dis. 2023;29:2587-2589.
    >> Share

    November 2023
  10. MODONGO C, Barilar I, Wang Q, Molefi T, et al
    Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Emerg Infect Dis. 2023;29:2403-2406.
    >> Share

    October 2023
  11. WINSTON CA, Marks SM, Carr W
    Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States.
    Emerg Infect Dis. 2023;29:2102-2104.
    >> Share

    August 2023
  12. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    >> Share

  13. LOUIE JK, Agraz-Lara R, Romo L, Deiterich C, et al
    Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California, USA.
    Emerg Infect Dis. 2023;29:1651-1654.
    >> Share

    July 2023
  14. WOODRUFF R, Miramontes R
    Tuberculosis Infection among Non-US-Born Persons and Persons >/=60 Years of Age, United States, 2019-2020.
    Emerg Infect Dis. 2023;29:1470-1472.
    >> Share

    May 2023
  15. NOROC E, Chesov D, Merker M, Groschel MI, et al
    Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova.
    Emerg Infect Dis. 2023;29:1046-1050.
    >> Share

  16. NGUYEN HV, Brals D, Tiemersma E, Gasior R, et al
    Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017-2018.
    Emerg Infect Dis. 2023;29:967-976.
    >> Share

  17. BAKER CR, Barilar I, de Araujo LS, Rimoin AW, et al
    Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana.
    Emerg Infect Dis. 2023;29:977-987.
    >> Share

  18. MILLARD J, Rimmer S, Nimmo C, O'Donnell M, et al
    Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB.
    Emerg Infect Dis. 2023;29:1081-1084.
    >> Share

    March 2023
  19. SHARMA M, Mathesh K, Dandapat P, Mariappan AK, et al
    Emergence of Mycobacterium orygis-Associated Tuberculosis in Wild Ruminants, India.
    Emerg Infect Dis. 2023;29:661-663.
    >> Share

  20. LUKOYE D, Gustavson G, Namuwenge PM, Muchuro S, et al
    Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016-2022.
    Emerg Infect Dis. 2023;29:609-613.
    >> Share

  21. MIYAHARA R, Piboonsiri P, Chiyasirinroje B, Imsanguan W, et al
    Risk for Prison-to-Community Tuberculosis Transmission, Thailand, 2017-2020.
    Emerg Infect Dis. 2023;29:477-483.
    >> Share

  22. MEESAWAT S, Warit S, Hamada Y, Malaivijitnond S, et al
    Prevalence of Mycobacterium tuberculosis Complex among Wild Rhesus Macaques and 2 Subspecies of Long-Tailed Macaques, Thailand, 2018-2022.
    Emerg Infect Dis. 2023;29:551-560.
    >> Share

    December 2022
  23. IHEKWEAZU C
    Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S299-S301.
    >> Share

    September 2022
  24. KHERABI Y, Frechet-Jachym M, Rioux C, Yazdanpanah Y, et al
    Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.
    Emerg Infect Dis. 2022;28:1796-1804.
    >> Share

  25. CAMPBELL JR, Nsengiyumva P, Chiang LY, Jamieson F, et al
    Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
    Emerg Infect Dis. 2022;28:1814-1823.
    >> Share

  26. LAEMMLE-RUFF I, Graham SM, Williams B, Horyniak D, et al
    Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.
    Emerg Infect Dis. 2022;28:1833-1841.
    >> Share

    July 2022
  27. SHEA J, Smith C, Halse TA, Kohlerschmidt D, et al
    Novel Mycobacterium tuberculosis Complex Genotype Related to M. caprae.
    Emerg Infect Dis. 2022;28:1431-1436.
    >> Share

    May 2022
  28. LE RAY LF, Aubry A, Sougakoff W, Revest M, et al
    atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
    Emerg Infect Dis. 2022;28:1062-1064.
    >> Share

    April 2022
  29. WINGLEE K, Hill AN, Langer AJ, Self JL, et al
    Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020.
    Emerg Infect Dis. 2022;28:820-827.
    >> Share

    March 2022
  30. HASAN T, Nguyen VN, Nguyen HB, Nguyen TA, et al
    Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
    Emerg Infect Dis. 2022;28:684-692.
    >> Share

  31. KHAN A, Phares CR, Phuong HL, Trinh DTK, et al
    Overseas Treatment of Latent Tuberculosis Infection in US-Bound Immigrants.
    Emerg Infect Dis. 2022;28:582-590.
    >> Share

  32. NATAPRAWIRA HM, Gafar F, Risan NA, Wulandari DA, et al
    Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia.
    Emerg Infect Dis. 2022;28:660-671.
    >> Share

    November 2021
  33. AUNG HL, Nyunt WW, Fong Y, Biggs PJ, et al
    Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
    Emerg Infect Dis. 2021;27:2847-2855.
    >> Share

    August 2021
  34. PAPAVENTSIS D, Dougas G, Kalkouni O, Karabela S, et al
    Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019.
    Emerg Infect Dis. 2021;27:1997-1999.
    >> Share

  35. LOUIE JK, Agraz-Lara R, Romo L, Crespin F, et al
    Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
    Emerg Infect Dis. 2021;27:2227-2229.
    >> Share

  36. GHIELMETTI G, Kupca AM, Hanczaruk M, Friedel U, et al
    Mycobacterium microti Infections in Free-Ranging Red Deer (Cervus elaphus).
    Emerg Infect Dis. 2021;27:2025-2032.
    >> Share

    July 2021
  37. SOKO RN, Burke RM, Feasey HRA, Sibande W, et al
    Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
    Emerg Infect Dis. 2021;27:1831-1839.
    >> Share

    June 2021
  38. TALWAR A, Li R, Langer AJ
    Association between Birth Region and Time to Tuberculosis Diagnosis among Non-US-Born Persons in the United States.
    Emerg Infect Dis. 2021;27:1645-1653.
    >> Share

    April 2021
  39. DE VAL BP, Romero B, Tortola MT, Leon LH, et al
    Polyresistant Mycobacterium bovis Infection in Human and Sympatric Sheep, Spain, 2017-2018.
    Emerg Infect Dis. 2021;27:1241-1243.
    >> Share

    March 2021
  40. MALIK AA, Gandhi NR, Lash TL, Cranmer LM, et al
    Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan.
    Emerg Infect Dis. 2021;27:805-812.
    >> Share

  41. LAFLEUR M, Reuter KE, Hall MB, Rasoanaivo HH, et al
    Drug-Resistant Tuberculosis in Pet Ring-Tailed Lemur, Madagascar.
    Emerg Infect Dis. 2021;27:977-979.
    >> Share

  42. WALTER KS, Tatara MB, Esther da Silva K, Moreira FMF, et al
    Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017.
    Emerg Infect Dis. 2021;27:905-914.
    >> Share

  43. NGUYEN HV, Nguyen HB, Nguyen NV, Cobelens F, et al
    Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017.
    Emerg Infect Dis. 2021;27:872-879.
    >> Share

  44. FAROOQ HZ, Cirillo DM, Hillemann D, Wyllie D, et al
    Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.
    Emerg Infect Dis. 2021;27:985-987.
    >> Share

  45. NONGHANPHITHAK D, Chaiprasert A, Smithtikarn S, Kamolwat P, et al
    Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
    Emerg Infect Dis. 2021;27:813-822.
    >> Share

  46. CUEVAS LE, Santos VS, Lima SVMA, Kontogianni K, et al
    Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic.
    Emerg Infect Dis. 2021;27:719-727.
    >> Share

  47. ZETOLA NM, Moonan PK, Click E, Oeltmann JE, et al
    Population-Based Geospatial and Molecular Epidemiologic Study of Tuberculosis Transmission Dynamics, Botswana, 2012-2016.
    Emerg Infect Dis. 2021;27:835-844.
    >> Share

  48. TAZERART F, Saad J, Niar A, Sahraoui N, et al
    Mycobacterium bovis Pulmonary Tuberculosis, Algeria.
    Emerg Infect Dis. 2021;27:972-974.
    >> Share

  49. CHITWOOD MH, Pelissari DM, Marques da Silva GD, Bartholomay P, et al
    Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017.
    Emerg Infect Dis. 2021;27:957-960.
    >> Share

  50. MILLER MA, Kerr TJ, de Waal CR, Goosen WJ, et al
    Mycobacterium bovis Infection in Free-Ranging African Elephants.
    Emerg Infect Dis. 2021;27:990-992.
    >> Share

    January 2021
  51. LEAVITT SV, Jacobson KR, Ragan EJ, Bor J, et al
    Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
    Emerg Infect Dis. 2021;27:728-739.
    >> Share

    December 2020
  52. MANDALAKAS AM, Kay AW, Bacha JM, Devezin T, et al
    Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa.
    Emerg Infect Dis. 2020;26.
    >> Share

    November 2020
  53. HALEY CA, Macias P, Jasuja S, Jones BA, et al
    Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
    Emerg Infect Dis. 2020;27.
    >> Share

  54. HOPEWELL PC, Reichman LB, Castro KG
    Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control.
    Emerg Infect Dis. 2020;27.
    >> Share

    March 2020
  55. KERR TJ, Gumbo R, Goosen WJ, Rogers P, et al
    Novel Techniques for Detection of Mycobacterium bovis Infection in a Cheetah.
    Emerg Infect Dis. 2020;26:630-631.
    >> Share

  56. POORANSINGH S, Sakhamuri S
    Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations.
    Emerg Infect Dis. 2020;26:624-625.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016